✦ LIBER ✦

Clinical benefit with cisplatin, hydroxyurea and 5-fluorouracil/ leucovorin in advanced pancreatic adenocarcinoma

✍ Scribed by E. Raymond; A. de Gramont; C. Louvet; C. Tournigand; B. Demuynck; K. Beerblock; E. Carola; M. Krulik

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Advanced esophageal cancer patients trea

✍ J. Taieb; P. Artru; C. Louvet; M. Mabro; E. Carola; E. Lucchi; M. Krulik; A. de 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Dose-intense PEFG (cisplatin, epirubicin

✍ M. Reni; S. Cereda; E. Bonetto; M. G. Viganò; P. Passoni; A. Zerbi; G. Balzano; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 345 KB

5-fluorouracil, leucovorin, hydroxyurea,

✍ Everett E. Vokes; Jill A. Moormeier; Mark J. Ratain; Merrill J. Egorin; Daniel J 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 815 KB

Treatment of patients with advanced colo

✍ Werner Scheithauer; H. Rosen; R. Schiessel; J. Schüller; M. Karall; F. Ernst; Ch 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 530 KB

Bimonthly regimen of high-dose leucovori

✍ Ilkay Tugba Unek, Tulay Akman, Ilhan Oztop, Olcun Umit Unal, Tarik Salman, Ugur 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 226 KB

Phase I study of matuzumab in combinatio

✍ Trarbach, Tanja; Przyborek, Marta; Schleucher, Norbert; Heeger, Steffen; Lüpfert 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 269 KB